JUNS
JUNS
NASDAQ · Pharmaceuticals

Jupiter Neurosciences Inc

$0.37
-0.01 (-2.87%)
As of Mar 25, 5:20 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +11,693.3% upside
Low Target $31.75
Average Target $43.93
High Target $69.04
Current Price $0.37
Current
$0.37
Target
$43.93
$31.75 $43.93 avg $69.04
Scenario Analysis
Bear Case
$31.75
8,423.5%
Low target
Base Case
$43.93
+11,693.3%
Avg target
Bull Case
$69.04
+18,434.2%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$3.33
-88.8% from high
52-Week Low
$0.34
+8.2% from low
Target vs 52W High
$43.93
+1,219.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%